Head-to-head · Cost-Efficiency Index
eMI Aesthetics vs Harbor
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
eMI Aesthetics
Shoppers wanting all-50-state compounded semaglutide or tirzepatide access with an AI progress simulator, willing to accept a price range rather than a fixed quote.
Visit eMI AestheticsHarbor
Cost-first shoppers who want price-sensitive shoppers who want a 'locked, no-increase' pricing promise on entry-tier compounded GLP-1s.
Visit HarborThe verdict
eMI Aesthetics and Harbor tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with eMI Aesthetics (ranked #99, a hair above #100) — Shoppers wanting all-50-state compounded semaglutide or tirzepatide access with an AI progress simulator, willing to accept a price range rather than a fixed quote. But Harbor is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs eMI Aesthetics.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | eMI Aesthetics | Harbor |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $179/mo (compounded) | $99/mo (starting dose, compounded) |
| Tirzepatide / mo | $269/mo (compounded) | $149/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,148 | $1,188 |
| Tirzepatide / yr (modeled) | $3,228 | $1,788 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Yes |
| Rank here | #99 | #100 |
eMI Aesthetics
69/100Where the value is
- Available to eligible patients in all 50 U.S. states per the site's own GLP-1 program page
- Offers semaglutide in both injectable and oral form, plus tirzepatide, on one platform
- Full program cost is bundled — evaluation, medication, delivery, coaching, and follow-up with no separate fees itemized
The tradeoffs
- The advertised '$179/month' is the FLOOR of a $179-$249 range for the injection alone; oral semaglutide runs $209-$279 and tirzepatide $269-$339 — the actual price a patient pays isn't disclosed before intake
- No specific dispensing pharmacy is named
Harbor
69/100Where the value is
- Among the lowest entry-tier prices seen in this set ($99 semaglutide / $149 tirzepatide)
- Explicit 'No Price Increases / Locked pricing' claim, addressing a common bait-and-switch risk
- LegitScript badge verifiably tied to the visitharbor.com domain itself
The tradeoffs
- 'As low as' framing without a visible full pricing/tier page (404'd)
- No individual is designated 'medical director' despite three physicians being pictured
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.